Total Payments
$35,616
2024 Payments
$5,104
Companies
57
Transactions
773
Medicare Patients
8,602
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$30,544 (85.8%)
Other$3,433 (9.6%)
Travel$1,607 (4.5%)
Education$31.16 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $30,544 | 761 | 85.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,433 | 3 | 9.6% |
| Travel and Lodging | $1,607 | 4 | 4.5% |
| Education | $31.16 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Synergy Pharmaceuticals Inc | $5,600 | 20 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $5,167 | 117 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,833 | 74 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,117 | 72 | $0 (2024) |
| Amgen Inc. | $3,054 | 64 | $0 (2024) |
| Novo Nordisk Inc | $2,356 | 80 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,328 | 33 | $0 (2024) |
| Allergan, Inc. | $1,167 | 23 | $0 (2020) |
| Lilly USA, LLC | $1,027 | 47 | $0 (2024) |
| ABBVIE INC. | $807.07 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,104 | 128 | AstraZeneca Pharmaceuticals LP ($948.64) |
| 2023 | $5,562 | 120 | GlaxoSmithKline, LLC. ($1,384) |
| 2022 | $3,660 | 102 | GlaxoSmithKline, LLC. ($848.65) |
| 2021 | $4,806 | 105 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,176) |
| 2020 | $2,280 | 83 | Amgen Inc. ($409.97) |
| 2019 | $3,300 | 91 | Boehringer Ingelheim Pharmaceuticals, Inc. ($561.49) |
| 2018 | $6,662 | 88 | Synergy Pharmaceuticals Inc ($5,600) |
| 2017 | $4,242 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,053) |
All Payment Transactions
773 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: DIABETES | ||||||
| 11/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), RELTONE 400 MG, GLYCATE | Food and Beverage | In-kind items and services | $117.31 | General |
| Category: GALLSTONES | ||||||
| 11/19/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: DIABETES | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: PAIN | ||||||
| 10/22/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: GI | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $120.29 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,982 | 7,295 | $1.6M | $539,048 |
| 2022 | 27 | 2,105 | 6,876 | $1.7M | $526,247 |
| 2021 | 28 | 2,360 | 7,381 | $1.8M | $577,225 |
| 2020 | 28 | 2,155 | 6,070 | $1.3M | $415,688 |
Total Patients
8,602
Total Services
27,622
Medicare Billing
$2.1M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 188 | 1,133 | $347,831 | $116,612 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 727 | $229,679 | $74,812 | 32.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 90 | 1,014 | $184,548 | $65,073 | 35.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 92 | 672 | $122,304 | $44,231 | 36.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 73 | 448 | $114,240 | $40,903 | 35.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 200 | 269 | $157,634 | $39,778 | 25.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 76 | 423 | $90,945 | $28,983 | 31.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 91 | 242 | $30,250 | $18,069 | 59.7% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 60 | 471 | $51,810 | $16,377 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 98 | 98 | $29,300 | $14,149 | 48.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 184 | $38,317 | $13,639 | 35.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 48 | 142 | $36,210 | $12,436 | 34.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 28 | 42 | $21,000 | $10,241 | 48.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 116 | 122 | $12,200 | $10,201 | 83.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 90 | 96 | $9,600 | $7,278 | 75.8% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 36 | 177 | $19,470 | $6,154 | 31.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 103 | 372 | $33,480 | $4,345 | 13.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 104 | 112 | $5,600 | $3,807 | 68.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $13,141 | $3,339 | 25.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 18 | $5,400 | $3,298 | 61.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $3,900 | $2,390 | 61.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 12 | 12 | $3,336 | $1,396 | 41.9% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 18 | 21 | $1,050 | $701.43 | 66.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 80 | 299 | $7,475 | $318.83 | 4.3% |
| J2010 | Injection, lincomycin hcl, up to 300 mg | Office | 2023 | 27 | 35 | $875.00 | $267.36 | 30.6% |
About Dr. Deepak Amin, MD
Dr. Deepak Amin, MD is a Internal Medicine healthcare provider based in Union City, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659372829.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepak Amin, MD has received a total of $35,616 in payments from pharmaceutical and medical device companies, with $5,104 received in 2024. These payments were reported across 773 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($30,544).
As a Medicare-enrolled provider, Amin has provided services to 8,602 Medicare beneficiaries, totaling 27,622 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Union City, NJ
- Active Since 08/09/2005
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659372829
Products in Payments
- Trulance (Drug) $5,600
- JARDIANCE (Drug) $5,365
- TRELEGY ELLIPTA (Drug) $1,749
- XARELTO (Drug) $1,203
- Repatha (Biological) $1,016
- BREZTRI (Drug) $970.36
- FARXIGA (Drug) $922.82
- Otezla (Drug) $856.71
- Aimovig (Biological) $813.10
- Ozempic (Drug) $763.73
- AREXVY (Drug) $716.30
- LINZESS (Drug) $617.08
- RELTONE 200 MG (Drug) $537.68
- Reveal LINQ (Device) $528.84
- VRAYLAR (Drug) $513.90
- RYBELSUS (Drug) $508.02
- Saxenda (Drug) $490.24
- SOLIQUA (Drug) $484.45
- Cologuard Collection Kit (Device) $482.46
- UBRELVY (Drug) $440.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Union City
Dwight Blake, Md, MD
Internal Medicine — Payments: $189,622
Internal Medicine $189,622
Dr. Paresh Shukla, M.d, M.D
Internal Medicine — Payments: $39,079
Internal Medicine $39,079
Dr. Jonathan Lowman, Md, MD
Internal Medicine — Payments: $30,543
Internal Medicine $30,543
Maria Campoalegre, M.d, M.D
Internal Medicine — Payments: $14,013
Internal Medicine $14,013
Dr. Rosa Calderon, M.d, M.D
Internal Medicine — Payments: $10,254
Internal Medicine $10,254
Dr. Mohammad Chaudhry, M.d, M.D
Internal Medicine — Payments: $7,859
Internal Medicine $7,859